NFKB1 and Hypertension: Inhibiting NF-κB pathway also improved hypertension and hyperlipemia symptoms, suggesting that TLR2 promotes inflammation through the activation of NF-κB pathway, thus inducing the occurrence and development of hypertension combined with hyperlipemia.